These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32448020)

  • 1. Glutamatergic and GABAergic reactivity and cognition in 22q11.2 deletion syndrome and healthy volunteers: A randomized double-blind 7-Tesla pharmacological MRS study.
    Vingerhoets C; Tse DH; van Oudenaren M; Hernaus D; van Duin E; Zinkstok J; Ramaekers JG; Jansen JF; McAlonan G; van Amelsvoort T
    J Psychopharmacol; 2020 Aug; 34(8):856-863. PubMed ID: 32448020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Riluzole effectively treats psychotic symptoms and improves cognition in 22q11.2 deletion syndrome: A clinical case.
    Vingerhoets C; Tse DHY; van Amelsvoort T
    Eur J Med Genet; 2019 Aug; 62(8):103705. PubMed ID: 31229682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered glutamatergic response and functional connectivity in treatment resistant schizophrenia: the effect of riluzole and therapeutic implications.
    Pillinger T; Rogdaki M; McCutcheon RA; Hathway P; Egerton A; Howes OD
    Psychopharmacology (Berl); 2019 Jul; 236(7):1985-1997. PubMed ID: 30820633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shifting brain inhibitory balance and connectivity of the prefrontal cortex of adults with autism spectrum disorder.
    Ajram LA; Horder J; Mendez MA; Galanopoulos A; Brennan LP; Wichers RH; Robertson DM; Murphy CM; Zinkstok J; Ivin G; Heasman M; Meek D; Tricklebank MD; Barker GJ; Lythgoe DJ; Edden RAE; Williams SC; Murphy DGM; McAlonan GM
    Transl Psychiatry; 2017 May; 7(5):e1137. PubMed ID: 28534874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamatergic function in a genetic high-risk group for psychosis: A proton magnetic resonance spectroscopy study in individuals with 22q11.2 deletion.
    Rogdaki M; Hathway P; Gudbrandsen M; McCutcheon RA; Jauhar S; Daly E; Howes O
    Eur Neuropsychopharmacol; 2019 Dec; 29(12):1333-1342. PubMed ID: 31648854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic regional variations of GABA, glutamine, and glutamate concentrations follow receptor fingerprints of human cingulate cortex.
    Dou W; Palomero-Gallagher N; van Tol MJ; Kaufmann J; Zhong K; Bernstein HG; Heinze HJ; Speck O; Walter M
    J Neurosci; 2013 Jul; 33(31):12698-704. PubMed ID: 23904606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Relationships between Dopaminergic, Glutamatergic, and Cognitive Functioning in 22q11.2 Deletion Syndrome: A Cross-Sectional, Multimodal
    van Hooijdonk CFM; Tse DHY; Roosenschoon J; Ceccarini J; Booij J; van Amelsvoort TAMJ; Vingerhoets C
    Genes (Basel); 2022 Sep; 13(9):. PubMed ID: 36140839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of anterior cingulate cortex gamma-aminobutyric acid and glutamate-glutamine levels in obsessive-compulsive disorder using magnetic resonance spectroscopy.
    Li Y; Zhang CC; Kathrin Weidacker ; Zhang Y; He N; Jin H; Chen W; Voon V; Edden RAE; Yan F
    BMC Psychiatry; 2019 May; 19(1):164. PubMed ID: 31146727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of striatal dopamine D2/3 receptor availability with GABA level in the anterior cingulate cortex in healthy controls but not in alcohol-dependent subjects and individuals at high risk: A multimodal magnetic resonance spectroscopy and positron emission tomography study.
    Spitta G; Gleich T; Rosenthal A; Schubert F; Aydin S; Heinz A; Buchert R; Gallinat J
    Addict Biol; 2024 Jun; 29(6):e13424. PubMed ID: 38899357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anterior cingulate Glutamate-Glutamine cycle metabolites are altered in euthymic bipolar I disorder.
    Soeiro-de-Souza MG; Henning A; Machado-Vieira R; Moreno RA; Pastorello BF; da Costa Leite C; Vallada H; Otaduy MC
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2221-9. PubMed ID: 26476706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anterior Cingulate Glutamate and GABA Associations on Functional Connectivity in Schizophrenia.
    Shukla DK; Wijtenburg SA; Chen H; Chiappelli JJ; Kochunov P; Hong LE; Rowland LM
    Schizophr Bull; 2019 Apr; 45(3):647-658. PubMed ID: 29912445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated striatal γ-aminobutyric acid in youth with major depressive disorder.
    Bradley KA; Alonso CM; Mehra LM; Xu J; Gabbay V
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():203-210. PubMed ID: 29890194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in excitatory and inhibitory neurotransmitter levels between depressed patients and healthy controls: A systematic review and meta-analysis.
    Godfrey KEM; Gardner AC; Kwon S; Chea W; Muthukumaraswamy SD
    J Psychiatr Res; 2018 Oct; 105():33-44. PubMed ID: 30144668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-Regional Glu-GABA vs Inter-Regional Glu-Glu Imbalance: A 1H-MRS Study of the Neurochemistry of Auditory Verbal Hallucinations in Schizophrenia.
    Hjelmervik H; Craven AR; Sinceviciute I; Johnsen E; Kompus K; Bless JJ; Kroken RA; Løberg EM; Ersland L; Grüner R; Hugdahl K
    Schizophr Bull; 2020 Apr; 46(3):633-642. PubMed ID: 31626702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotransmitter changes during interference task in anterior cingulate cortex: evidence from fMRI-guided functional MRS at 3 T.
    Kühn S; Schubert F; Mekle R; Wenger E; Ittermann B; Lindenberger U; Gallinat J
    Brain Struct Funct; 2016 Jun; 221(5):2541-51. PubMed ID: 25976598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocannabinoid levels in plasma and neurotransmitters in the brain: a preliminary report on patients with a psychotic disorder and healthy individuals.
    van Hooijdonk CFM; Balvers MGJ; van der Pluijm M; Smith CLC; de Haan L; Schrantee A; Yaqub M; Witkamp RF; van de Giessen E; van Amelsvoort TAMJ; Booij J; Selten JP
    Psychol Med; 2024 Jul; 54(9):2189-2199. PubMed ID: 38389452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous quantification of GABA, Glx and GSH in the neonatal human brain using magnetic resonance spectroscopy.
    Maria YL; Price AN; Puts NAJ; Hughes EJ; Edden RAE; McAlonan GM; Arichi T; De Vita E
    Neuroimage; 2021 Jun; 233():117930. PubMed ID: 33711485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis.
    Bojesen KB; Ebdrup BH; Jessen K; Sigvard A; Tangmose K; Edden RAE; Larsson HBW; Rostrup E; Broberg BV; Glenthøj BY
    Psychol Med; 2020 Oct; 50(13):2182-2193. PubMed ID: 31524118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seizures and neurodegeneration induced by 4-aminopyridine in rat hippocampus in vivo: role of glutamate- and GABA-mediated neurotransmission and of ion channels.
    Peña F; Tapia R
    Neuroscience; 2000; 101(3):547-61. PubMed ID: 11113304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline measures of cerebral glutamate and GABA levels in individuals at ultrahigh risk for psychosis: Implications for clinical outcome after 12 months.
    Wenneberg C; Glenthøj BY; Glenthøj LB; Fagerlund B; Krakauer K; Kristensen TD; Hjorthøj C; Edden RAE; Broberg BV; Bojesen KB; Rostrup E; Nordentoft M
    Eur Psychiatry; 2020 Aug; 63(1):e83. PubMed ID: 32762779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.